These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32805692)

  • 1. Corrigendum to "HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE)" [Int. Immunopharmacol. 78 (2020) 105943].
    Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaeia M; Keyvani H
    Int Immunopharmacol; 2020 Nov; 88():106742. PubMed ID: 32805692
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
    Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
    Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Neuroprotective effect of Vesatolimod in an experimental autoimmune encephalomyelitis mice model" [Int. Immunopharmacol. 116 (2023) 109717].
    Jiang X; Song Y; Fang J; Yang X; Mu S; Zhang J
    Int Immunopharmacol; 2024 Feb; 128():111448. PubMed ID: 38191277
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance" [Int. Immunopharmacol. 119 (2023) 110160].
    Gharibi T; Barpour N; Hosseini A; Mohammadzadeh A; Marofi F; Ebrahimi-Kalan A; Nejati-Koshki K; Abdollahpour-Alitappeh M; Safaei S; Baghbani E; Baradaran B
    Int Immunopharmacol; 2023 Jun; 119():110303. PubMed ID: 37179201
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo monitoring the fate of Cy5.5-Tat labeled T lymphocytes by quantitative near-infrared fluorescence imaging during acute brain inflammation in a rat model of experimental autoimmune encephalomyelitis.
    Berger C; Gremlich HU; Schmidt P; Cannet C; Kneuer R; Hiestand P; Rausch M; Rudin M
    J Immunol Methods; 2007 May; 323(1):65-77. PubMed ID: 17433359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Paeonol derivative-6 attenuates inflammation by activating ZEB2 in acute liver injury" [Int. Immunopharmacol. 91 (2021) 107235].
    Yang J; Xu L; Wu M; Fang H; Lu Y; Shi C; Wang Y; Li Z; Zhang L; Zhang L
    Int Immunopharmacol; 2021 May; 94():107410. PubMed ID: 33578262
    [No Abstract]   [Full Text] [Related]  

  • 7. Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis.
    Bernardes D; Brambilla R; Bracchi-Ricard V; Karmally S; Dellarole A; Carvalho-Tavares J; Bethea JR
    J Neurochem; 2016 Jan; 136 Suppl 1():63-73. PubMed ID: 26364732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "Methylallyl sulfone attenuates inflammation, oxidative stress and lung injury induced by cigarette smoke extract in mice and RAW264.7 cells" Int Immunopharmacol, volume 59, 2018, 369-374.
    Li A; Liu Y; Zhu X; Sun X; Feng X; Li D; Zhang J; Zhu M; Zhao Z
    Int Immunopharmacol; 2019 Jul; 72():522. PubMed ID: 30922802
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Sodium houttuyfonate enhances the intestinal barrier and attenuates inflammation induced by Salmonella typhimurium through the NF-κB pathway in mice" [Int. Immunopharmacol. 89 (2020) 107058].
    Zhang L; Lv H; Li Y; Dong N; Bi C; Shan A; Wu Z; Shi B
    Int Immunopharmacol; 2021 Mar; 92():107351. PubMed ID: 33444920
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice" [Int. Immunopharmacol. 79 (2020) 106180].
    Cheng Y; Chen B; Xie W; Chen Z; Yang G; Cai Y; Shang H; Zhao W
    Int Immunopharmacol; 2020 Jul; 84():106461. PubMed ID: 32278662
    [No Abstract]   [Full Text] [Related]  

  • 11. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma thrombin-antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis.
    Inaba Y; Ichikawa M; Inoue A; Itoh M; Kyogashima M; Sekiguchi Y; Nakamura S; Komiyama A; Koh C
    J Neurol Sci; 2001 Apr; 185(2):89-93. PubMed ID: 11311288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ion channels and demyelination: basis of a treatment of experimental autoimmune encephalomyelitis (EAE) by potassium channel blockers].
    Devaux J; Beeton C; Béraud E; Crest M
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S16-27. PubMed ID: 15269656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "Emodin attenuates acute lung injury in cecal-ligation and puncture rats" [Int. Immunopharmacol. 85 (2020) 106626].
    Guo R; Li Y; Han M; Liu J; Sun Y
    Int Immunopharmacol; 2023 Sep; 122():110700. PubMed ID: 37507324
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Modulating endoplasmic reticulum stress attenuates mast cell degranulation" [Int. Immunopharmacol. 126 (2024) 111336].
    Fan J; Ma L; Xie B; Qiu S; Song S; Tang Z; Wu Y; Huangfu H; Feng Y; Luo X; Yang P
    Int Immunopharmacol; 2024 Aug; 137():112497. PubMed ID: 38902129
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice" [Int. Immunopharmacol. 102 (2022) 108411].
    Hao J; Sun W; Xu H
    Int Immunopharmacol; 2022 Mar; 104():108550. PubMed ID: 35067473
    [No Abstract]   [Full Text] [Related]  

  • 17. Exercise training attenuates experimental autoimmune encephalomyelitis by peripheral immunomodulation rather than direct neuroprotection.
    Einstein O; Fainstein N; Touloumi O; Lagoudaki R; Hanya E; Grigoriadis N; Katz A; Ben-Hur T
    Exp Neurol; 2018 Jan; 299(Pt A):56-64. PubMed ID: 29031957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420].
    Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
    Int Immunopharmacol; 2024 Apr; 131():111694. PubMed ID: 38368241
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187].
    Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
    Int Immunopharmacol; 2023 Nov; 124(Pt A):111008. PubMed ID: 37806791
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs" [Int. Immunopharmacol. 61 (2018) 1-7].
    Chen L; Lu Y; Zhao L; Hu L; Qiu Q; Zhang Z; Li M; Hong G; Wu B; Zhao G; Lu Z
    Int Immunopharmacol; 2024 Aug; 137():112471. PubMed ID: 38879417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.